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Quantitative microscopyStress granule (SG) assembly represents a conserved eukaryotic defense strategy against various insults.
Although essential for the ability to cope with deleterious conditions, the signaling pathways controlling SG
formation are not fully understood. The energy sensor AMP-activated protein kinase (AMPK) is critical for the
cellular stress response. Human cells produce twoAMPK catalyticα-subunitswith not only partially overlapping,
but also unique functions. Here, we provide direct support for structural and functional links between AMPK-α
isoforms and SGs. As such, several stressors promote SG association of AMPK-α2, but not AMPK-α1. Multiple
lines of evidence link AMPK activity to SG biogenesis. First, pharmacological kinase inhibition interfered with
SG formation. Second, AMPK-α knockdown combined with in-depth quantitative SG analysis revealed
isoform-speciﬁc changes of SG characteristics. Third, overexpression of mutant α-subunits further substantiated
that AMPK regulates SGparameters. Finally, we identiﬁed the SG-nucleating protein G3BP1 as anAMPK-α2 bind-
ing partner. This interaction is stimulated by stress and notably occurs in SGs. Collectively, our data deﬁne the
master metabolic regulator AMPK as a novel SG constituent that also controls their biogenesis.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Eukaryotic cells have evolved different strategies to control energy
expenditure and survival during environmental or physiological stress.
One of the main mechanisms is stress granule (SG) formation in the
cytoplasm, where SGs store translationally arrested mRNAs that are as-
sociated with a diverse set of proteins and protect cells from apoptosis
[1,2]. SG biogenesis is a conserved stress response; in most cases, SG
assembly is induced by phosphorylation of the translation initiation fac-
tor eIF2α. This results in polysome disassembly, translation arrest and
subsequent SG formation [3,4]. However, SGs can also form indepen-
dently of eIF2α phosphorylation [5,6]. SG nucleation is initiated by the
oligomerization of G3BP1 (Ras GTPase-activating protein-binding
protein 1) and aggregation of prion-like domains of the RNA binding
proteins TIA-1/TIAR [7,8]. Secondary recruitment of additional proteins
produces mature SGs [9], which vary in RNA and protein composition
according to the type of stress [4,10,11].
Recent studies have begun to decipher the signaling events that
control SG formation. For example, focal adhesion kinase (FAK) is
recruited to SGs and regulates SG dynamics during the recovery fromse; CC, compound C; DAPI, 4′,6-
cence; FBS, fetal bovine serum;
wn;PBS,phosphate-bufferedsa-
1 514 398 7452.stress [12]. RhoA and the downstream kinase ROCK1 also associate
with SGs and are involved in their assembly [13]. At the same time, SG
formation can also control intracellular signaling and cell fate. For
example, RACK1 sequestration in SGs inhibits apoptosis-inducing p38
and JNK pathways and thus favors cell survival [1]. In addition, the ener-
gy sensing mTOR pathway regulates cell survival through the SG
recruitment of Raptor [14]. Thus, SGs are important signaling hubs
that control key cellular decisions [2,15]. However, the signaling path-
ways regulating SG biogenesis are far from being fully understood.
One of the stress responsive kinases is AMPK, a central regulator of
energy homeostasis in eukaryotes [16,17]. When cellular ATP pools
are depleted, the kinase is activated; as a result, cells shift from anabolic
to catabolic processes ([18]; reviewed in [19]). AMPK impinges on
numerous cell functions, ranging from autophagy, cell growth and
polarity to cytoskeletal dynamics [20–24].
The heterotrimeric AMPK (αβγ) contains one catalytic α subunit
which is encoded by two genes (α1 and α2). The regulatory β and γ
subunits are encoded by two and three genes, respectively [25]. The
role of AMPK as a key regulator of metabolism requires a tight control
of the enzyme [26–29]. The most important step for AMPK activation
is the phosphorylation of its α-subunit on Thr183 (human α1) or
Thr172 (human α2), a modiﬁcation catalyzed by several upstream
kinases [30].
Interestingly, the twoα-isoformshave overlapping aswell as unique
functions. For instance, both AMPK-α1 and AMPK-α2 reduce cell death
upon metabolic stress, and the two subunits can substitute for each
other [31]. Isoform-speciﬁc functions for AMPK-α2 include the
Fig. 1. AMPK-α1/2 localizes to SGs in response to oxidative stress. HeLa cells were incubated with the vehicle water or ethanol, and SG formation was induced with arsenite or DEM
(Materials and methods). Antibodies against AMPK-α1/2 recognize both isoforms of the α-subunit. A portion of AMPK-α1/2 associated with SGs which were identiﬁed with the marker
proteins HuR or G3BP1. DNA was visualized with DAPI. Magniﬁed (500×) sections show the co-localization of AMPK-αwith the SG marker protein in the overlay. Scale bar is 20 μm.
1726 H. Mahboubi et al. / Biochimica et Biophysica Acta 1853 (2015) 1725–1737regulation of transcription and tumor survival in high grade gliomas,
while AMPK-α1 modulates the neurotoxicity of Huntington's disease
[32,33]. Moreover, AMPK-α1 activation causes a nucleocytoplasmic
redistribution of TDP43, a SG protein that is linked to neurodegenerative
disorders [34,35].
Here, we deﬁned the role of AMPK for SG biogenesis and identiﬁed
α-isoform-speciﬁc contributions to this process. To our knowledge,
our studies are the ﬁrst to demonstrate a direct link between AMPK
and SG biogenesis.
2. Materials and methods
2.1. Cell culture, stress and drug treatment
HeLa cells were grown in Dulbecco's modiﬁed eagle medium
(DMEM) containing antibiotics and 8% fetal bovine serum (FBS).
Cultures were maintained in a 37 °C incubator containing 5% CO2. Toinduce oxidative stress, HeLa cells were treated with 0.5 mM sodium
arsenite or sterile water (control) for 1 h. Alternatively, HeLa cells
were incubated with 2 mMdiethyl maleate (DEM) or ethanol (control)
for 4 h. For treatment with compound C (CC), cells were pre-incubated
for 1 h with DMSO (vehicle) or 40 mM CC and subsequently incubated
with ethanol or DEM; DMSO or CC was present throughout the stress
exposure. For energy depletion, 10 mM sodium azide was combined
with 50 mM 2-deoxyglucose (NDG); cells were treated for 30 min and
controls were incubated with water. To induce SGs independent of
eIF2α phosphorylation [36], HeLa cells were exposed for 30 min to
0.1 μM Pateamine A (generously provided by Drs. Gallouzi and
Pelletier).
2.2. Indirect immunoﬂuorescence
Cells were grown to 70% conﬂuency on poly-lysine coated cover
slips. After treatment, immunoﬂuorescent staining was performed
Fig. 2. AMPK-α isoforms are differentially recruited to SGs. Cells were treated as described for Fig. 1 and incubated with antibodies speciﬁc for AMPK-α1 or AMPK-α2. AMPK-α2 was
present in SGs induced by arsenite or DEM. By contrast, little or no SG staining was observed for AMPK-α1. (A) SGs were identiﬁed with HuR; (B) SGs were demarcated with G3BP1.
Selected SGs were magniﬁed (500×) to show the colocalization (yellow) of AMPK-αwith SG marker proteins. Scale bar is 20 μm.
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α1/2 (1:200; Santa Cruz sc-74461), AMPK-α1 and AMPK-α2 (1:2000;
Bethyl A300-507A, A300-508A), AMPK-β1/2 (1:400; Cell Signaling
#4150), AMPK-γ1 (1:200; Cell Signaling #4187), AMPK-γ2 (1:200;
Cell Signaling #2536), HuR (1:2000; sc-5261), TIA-1/TIAR (1:1000; sc-
28237), G3BP1 (1:1000; BD Biosciences #611126), and myc-epitope
(1:1000; sc-40). In brief, cells were ﬁxed with 3.7% formaldehyde in
phosphate-buffered saline (PBS), permeabilized with 0.1% Triton X-
100 in PBS/2 mg/BSA and blocked for 1 h in PBS containing 5% FBS,
0.05% Tween-20 and 1 mM NaN3. Samples were incubated overnight
with primary antibodies diluted in PBS/FBS/Tween. Puriﬁed Alexa
Fluor® 488, Alexa Fluor® 647 and Cy3 ﬂuorescently-labeled secondary
antibodies were added the following day for 2 h [38]. Nuclei were
visualized with 1 μg/ml 4′,6-diamidino-2-phenylindole (DAPI). The
speciﬁcity of primary antibodies against AMPK subunits and SGmarker
proteins was evaluated (Suppl. Fig. 1 [38] and [39]). Cover slips were
mounted on glass slides and images acquired in the multi-track mode
with a Zeiss LSM510 confocal microscope. Appropriate ﬁlter settings
were chosen to minimize cross-talk between channels. Images were
processed in Adobe Photoshop 8.0. 3D reconstruction and surface
rendering were performed with Imaris software (Bitplane) on confocal
stacks acquired with 0.35 μm intervals.2.3. Gene silencing
FastFect (Feldan) was used to transfect HeLa cells with shRNA
plasmids according to the manufacturer's protocol. Transfected cells
were identiﬁed by co-transfection of a plasmid encoding theﬂuorescent
protein mCherry. Two sequences targeting different regions of the
AMPK-α1 or α2 genes were used for each knockdown (Table S1); the
control shRNA-construct contained a scrambled sequence. All se-
quences were blasted against the human genome to verify appropriatetarget recognition. After a 3-day knockdown period cells were exposed
to stress and analyzed.2.4. Transfection of plasmid DNA
Plasmid DNAwas introduced into HeLa cells with FastFect as recom-
mended by the manufacturer. All constructs contained a pcDNA3.1
backbone and encoded a myc-tagged protein. The myc-tag was used
to identify transfected cells. The K45R AMPK-α2 mutant (provided by
Dr. M. Birnbaum [40]) codes for a kinase-dead protein and is dominant
negative. A constitutively active AMPK-α2mutantwith T172D substitu-
tion was generated by site-speciﬁc mutagenesis; the correctness of the
construct was veriﬁed by DNA sequencing. A plasmid encoding a C-
terminal fragment of DNAJA2 (gift from J. Young, McGill University)
produces an inactive protein and served as control [41]. 24 h after
transfection, cells were incubated with oxidant or vehicle and then
processed for immunoﬂuorescence.2.5. Image quantiﬁcation
SGs were quantiﬁed with MetaXpress software according to our
published procedures [11]. In brief, individual cells were identiﬁed
based on the staining with DAPI and the transfection marker. Following
background correction, SG parameters weremeasured using G3BP1 as a
marker for the compartment. All steps were recorded in a custom-
designed journal to automate the quantiﬁcation.2.6. Cell death assessment
Nuclear fragmentation of DAPI-stained ﬁxed and mounted cells was
scored to evaluate cell death.
Fig. 3. Energy depletion induces SG assembly and activates AMPK. HeLa cells were energy
depleted with sodium azide and 2-deoxyglucose (NDG). (A, B) Fixed cells were analyzed
by indirect immunoﬂuorescence with antibodies against AMPK-α1, AMPK-α2, HuR (part
A) or G3BP1 (part B), as indicated. Scale bar is 20 μm. (C)Western blotting conﬁrmed the
increased phosphorylation of AMPK-α in energy-depleted cells.
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HeLa cell proteins were solubilized in gel sample buffer as described
[42]. Samples were incubated at 95 °C for 10 min and vortexed with sil-
ica beads to shear DNA. Proteins were precipitated with trichloroaceticacid for 20 min on ice and collected by centrifugation (microfuge,
1min at 13,000 rpm). Sedimentswere resuspended in gel sample buffer
and analyzed by Western blotting.
2.8. Western blotting
Western blotting and ECL followed standard procedures. Primary
antibodies were used at the following dilutions: AMPK-α1/2 (1:200),
p-AMPK-α (1:2000; Cell Signaling #2535), p-Acc1 (1:1000;
phosphoSer79; Cell Signaling #3661); Acc1 (1:500; Cell Signaling
#3662), HuR (1:2000), G3BP1 (1:2000), TIA-1/TIAR (1:1000), AMPK-
α1 and AMPK-α2 (1:2000), and actin (1:100,000; Chemicon). Primary
antibodies were detected with HRP-conjugated secondary antibodies.
2.9. Proximity ligation assay (PLA)
PLAwas performedwith the Duolink II kit (Olink Bioscience), essen-
tially as recommended by the manufacturer. In brief, samples were
ﬁxed, permeabilized, blocked and incubated with primary antibodies
as described above. Samples were then washed with blocking buffer
and incubated for 1 h at 37 °C with secondary antibodies conjugated
with PLA probes. After two washes with buffer A (Olink Bioscience),
the ligation was performed for 30 min at 37 °C, followed by ampliﬁca-
tion (100min at 37 °C) and ﬁnal washes with buffer B. After completing
all PLA steps, Alexa Fluor®488 conjugated secondary antibodies were
added for 2 h at room temperature, samples were washed in blocking
buffer, incubated with DAPI and mounted.
2.10. Co-immunoprecipitation
Reversible protein crosslinking with Dithiobis (succinimidyl propio-
nate) and immunoprecipitation were essentially as described [43]. In
brief, after incubation with DEM or vehicle, crosslinking was carried
out for 15 min at room temperature. Samples were rinsed with PBS
and 50 mM Tris HCl pH 7.4/150 mM NaCl and stored at −70 °C. For
immunoprecipitation, cell extracts were incubated overnight at 4 °C
with 1.5 μg anti-G3BP1 or non-speciﬁc mouse IgG. Protein G-
Sepharose was then added for 2 h at 4 °C. The resin was washed,
bound material separated on 7.5–10% acrylamide gradient gels and
analyzed by Western blotting [43]. Filters were probed with anti-
G3BP1 antibodies, stripped and reprobed with anti-AMPK-α2. Bound
AMPK-α2 antibodies were detected with HRP-conjugated secondary
antibodies speciﬁc for rabbit IgG light chains (Jackson Labs., #211-
032-171). ECL signals were quantiﬁed, and the ratio AMPK-α2/G3BP1
was calculated. Results were normalized to the control sample.
2.11. Statistics
At least three independent experiments were performed for each
assay/condition and one-way ANOVA analysis was carried out to
identify signiﬁcant differences; * p b 0.05; ** p b 0.01. Results for
co-immunoprecipitation are shown for four independent experi-
ments; data for controls and treated samples were compared by
Student's t test.
3. Results and discussion
3.1. Oxidative stress targets AMPK to SGs
Under normal growth conditions, AMPK resides in the nucleus or
cytoplasm, shuttling between the two compartments [37]. Stressors
that promote SG formation also alter the intracellular AMPK
distribution. These conditions increase AMPK concentrations in nu-
clei [37]; the fate of cytoplasmic kinase pools, however, is not well
deﬁned.
Fig. 4. AMPK-α2 is recruited to SGs that form independent of eIF2α phosphorylation. HeLa cells were incubated with vehicle DMSO or Pateamine A (PatA) and then processed for the
immunodetection of (A) AMPK-α and HuR, or (B) AMPK-α and G3BP1. Scale bar is 20 μm, nuclei were stained with DAPI.
Fig. 5. Compound C impairs SG formation. (A) HeLa cells were pre-incubated with the vehicle DMSO or CC for 1 h; DMSO or CC was also present throughout the subsequent treatment
period. SG assembly was induced by arsenite; the vehicle water was added to controls. Alternatively, SGs were produced with DEM, whereas controls received ethanol. AMPK-α1/2
was detected in SGs demarcated with the marker HuR. (B) The same results as in part A were obtained with the SG marker G3BP1. Scale bar is 20 μm. (C) Western blots for control
and DEM-treated samples show a reduction ofα-subunit phosphorylation (α1, Thr183; α2, Thr172) after DEM incubation. CC further diminishes this modiﬁcation. The loss of AMPK ki-
nase activity was veriﬁed by probing for phosphorylated Acc1 (p-Acc1). Phosphorylation of eIF2α on Ser51 was not abolished by DEM or CC. DEM or CC had also no strong effects on the
cellular concentrations of TIA-1/TIAR, G3BP1 or HuR.
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Fig. 6. AMPK-α knockdown has isoform-speciﬁc effects on SGs. The impact of AMPK-α1 or AMPK-α2 knockdown was assessed in cultured cells. (A) Isoform-speciﬁc knockdown was
analyzed by quantitativeWestern blotting. Note that AMPK-α1 knockdown upregulates the concentration of AMPK-α2, whereas AMPK-α2 knockdown also diminishes the α1-isoform
levels. Similar results were obtained for two different constructs targeting each isoform. Results are shown as average+ SEM for three independent experiments. (B) Cells knocked down
for AMPK-α isoformswere identiﬁedwith the transfectionmarkermCherry. SGs inDEM-or ethanol-treated cellswere demarcatedwithG3BP1. Scale bar is 20 μm. (C) SGparameterswere
quantiﬁed for three independent experiments. AMPK-α2 knockdown reduced the number of SGs/cell, the total SG area/cell and the SG pixel intensity/cell.
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Fig. 7. AMPK-α1 or AMPK-α2 knockdown signiﬁcantly increases the number of cells with
nuclear fragmentation, indicating cell death. One-way ANOVA identiﬁed signiﬁcant
changes for all quantitative measurements; * p b 0.05; ** p b 0.01.
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diethyl maleate (DEM), a compound that induces SGs [11]. In DEM-
treated cells, AMPK-α1/2 associated in the cytoplasm with granular
compartments that colocalized with the SG markers G3BP1 and HuR
(Fig. 1). (Suppl. Fig. 1 veriﬁed the speciﬁcity of AMPK antibodies used
for our studies.)Fig. 8. A dominant-negative mutant of AMPK-α2 changes SG parameters. HeLa cells were tran
constitutively active (CA) form of AMPK-α2. Cells were exposed to DEM or the vehicle ethan
G3BP1 and myc-tagged proteins were detected; all images were acquired and processed with
parameters were quantiﬁed as described in Fig. 6. Results are shown for three independent
were normalized to the control DNA. Note that dominant-negative AMPK-α2 reduced signiﬁc
DEM-treated samples; results for the control plasmid served as reference).Since the SG composition depends on the type of stress, we also
evaluated sodium arsenite, an oxidant frequently used to produce
SGs. As for DEM, AMPK-α1/2 located to SGs in arsenite-treated
cells (Fig. 1).3.2. AMPK-α isoforms are differentially recruited to SGs
To identify the catalytic subunit(s) associatedwith SGs,we immuno-
stained stressed cells with isoform-speciﬁc antibodies. AMPK-α2 was
present in all SGs induced by DEM or arsenite (Fig. 2). By contrast,
AMPK-α1 was detected only in few SGs of DEM-treated cells; these
SGs were particularly large. This isoform-dependent distribution of
AMPK-α subunits was veriﬁed with different isoform-speciﬁc primary
antibodies (Fig. 2, Fig. 1 in [39]). Furthermore, we conﬁrmed these ﬁnd-
ings in another cell type from a distinct organism (mouse embryonic
ﬁbroblasts, Fig. 2 in [39]). As AMPK is a heterotrimeric enzyme that
contains β and γ subunits, we also assessed the presence of these regu-
latory proteins in SGs (Figs. 3–5 in [39]). In parallel, control experiments
evaluated the non-speciﬁc staining with secondary antibodies alone.
Following oxidative stress, β-subunits associated with SGs (Fig. 3 in
[39]). While SG staining was not observed for the γ1 subunit (Fig. 4 in
[39]), γ2 was detected in the SGs produced upon DEM treatment and
in large arsenite-induced SGs (Fig. 5 in [39]). Since PRKAG3, the genesiently transfected with control DNA, or plasmids encoding a dominant-negative (DN) or
ol (EtOH), ﬁxed and analyzed by quantitative immunoﬂuorescence. (A) The SG marker
identical settings. Scale bar is 20 μm, nuclei were demarcated with DAPI. (B) Different SG
experiments; at least 63 cells were quantiﬁed per experiment for each plasmid. Results
antly the number of SGs/cell and the total SG area/cell (**, p b 0.01; one-way ANOVA for
Fig. 9. AMPK-α2 interacts with G3BP1 in SGs. Cell were incubated with DEM as described for Fig. 1. Following the incubation with primary antibodies against AMPK-α2 and G3BP1, the
proximity of both proteinswas examined by PLA (red signal; Materials andmethods). After PLA, secondary antibodies against G3BP1 demarcated SGs (green). (A) PLA reveals that AMPK-
α2 andG3BP1 are in close contact; this association occurs at least in part in SGs. Themagniﬁed regiondisplays SGs that show an interaction betweenAMPK-α2 andG3BP1. This association
takes place only in a portion of the SG area. In control experiments one of the primary antibodieswas omitted; all other steps were identical. All images were acquired at identical settings.
Scale bar is 20 μm. (B) HuR and TIA-1/TIAR provided a positive control for proteins interacting in SGs. (C) 3D-reconstruction deﬁnes regionswhere AMPK-α2 andG3BP1 are in close prox-
imity (red). SGs were demarcated by immunolocalizations of G3BP1 (green). AMPK-α2 and G3BP1 associate in SGs, and additional contact sites are present in the cytoplasm. Scale bar is
1 μm.
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not include the γ3 subunit in our studies. Future experiments will have
to undertake a comprehensive assessment of how regulatory AMPK
subunits interact with SGs.3.3. AMPK-α2 associates with SGs that are generated by metabolic stress or
Pateamine A
Experiments in Fig. 2 demonstrated that oxidants promote the SG
association of AMPK-α2. To further characterize the SG recruitment of
AMPK, we exposed cells to metabolic stress caused by energy-
depletion. As observed for oxidants, AMPK-α2, but not AMPK-α1, was
detected in SGs after the combined treatment with sodium azide and
2-deoxyglucose (Fig. 3).Under many conditions, SG formation is stimulated by the
phosphorylation of eIF2α on Ser51.While this modiﬁcation is not man-
datory to produce SGs, SGs assembled in the absence of eIF2α
phosphorylation can differ in their composition [6]. The translation
inhibitor Pateamine A induces SGs without promoting Ser51 phosphor-
ylation of eIF2α [36]. In HeLa cells, SGs assembled upon Pateamine A
incubation contained the marker proteins HuR and G3BP1, as well as
AMPKα (Fig. 4). Like other stressors, AMPKα binding was isoform-
speciﬁc; AMPK-α2, but not AMPK-α1, associated with SGs produced
by Pateamine A (Fig. 4).
Taken together, upon oxidative, metabolic or drug-induced stress,
SGs are assembled that contain AMPK-α2, but not AMPK-α1. In addi-
tion to the catalytic α2 subunit, some regulatory AMPK subunits also
located to SGs. This establishes AMPK-α2 as a bona ﬁde SG component
in different cell types and organisms. Notably, AMPK-α2 is recruited
Fig. 10. AMPK-α2 and G3BP1 associate in control and stressed cells. HeLa cells were
incubated with vehicle (EtOH) or DEM, and crude extracts were processed for
immunoprecipitation (IP) with antibodies against G3BP1. Start indicates 20% of the
starting material for the IP. Immunopuriﬁedmaterial obtained for anti-G3BP1 and isotype
control IgG were run side-by-side. The ﬁlter was ﬁrst probed with antibodies against
G3BP1, stripped and then reprobed with anti-AMPK-α2 antibodies. ECL signals obtained
for G3BP1 and AMPK-α2 were quantiﬁed, the ratio AMPK-α2/G3BP1 was calculated and
normalized to the control. The graph depicts the results of four independent experiments;
it shows that the association of AMPK-α2 with G3BP1 signiﬁcantly increased upon
oxidative stress (Student's t test).
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pathways. This supports the idea that AMPK-α2 controls SG formation
for a wide variety of stress conditions.
3.4. The enzymatic activity of AMPK is required for proper SG formation
To examine the role of AMPK activity for SGs, we blocked its kinase
activity with the pharmacological inhibitor compound C [CC, [45]].
Immunoﬂuorescence studies and Western blotting showed that the
phosphorylation of AMPK-α1/2 and its downstream target Acc1 were
greatly reduced by the inhibitor (Fig. 5A–C). Treatment with CC dimin-
ished the size of oxidant-induced SGs as revealed by the marker
proteins HuR and G3BP1 (Fig. 5A, B). Notably, AMPK inhibition did not
prevent its recruitment to SGs. While SGs were smaller in CC-treated
cells, they still contained AMPK-α (Fig. 5A).We observed the same out-
comewith sodiumarsenite (Fig. 3B), suggesting that independent of the
type of oxidant AMPK is required to produce mature SGs. In line with
the presence of SGs in CC-treated cells, the compound did not prevent
the phosphorylation of eIF2α upon oxidative stress (Fig. 5C). Further-
more, no profound changes were caused by CC for the concentrations
of SG core proteins TIA-1/TIAR, G3BP1 or HuR. These data support a
model proposing that the enzymatic activity of AMPK is required to
assemble SGs of normal size. However, AMPK is not essential to
promote the stress-induced phosphorylation of eIF2α and the initial
steps of SG assembly. Accordingly, AMPK is likely to control the growth
of SGs.
Others reported recently that CC reduces the size of SGs that were
generated upon cold shock [46]. However, direct evidence that impli-
cates AMPK in SG assembly is missing. The following section imparts
this information. Moreover, it identiﬁes the speciﬁc SG parameters
that are regulated by AMPK.
3.5. AMPK-α isoform-speciﬁc regulation of SGs
Although CC is commonly used to inhibit AMPK, the agent has off-
target effects [47–49]. A shRNA silencing approach will provide
independent and direct evidence to substantiate the role of AMPK for
SG formation. To this end, two different constructs were generated for
each of the two α-subunits. Isoform-speciﬁc antibodies veriﬁed the
knockdown efﬁciency of all constructs by Western blotting (Fig. 6A).
Notably, depletion of the AMPK-α1 subunit increased signiﬁcantly
AMPK-α2 protein levels, indicating a compensatory mechanism to
restore AMPK activity. By contrast, AMPK-α2 knockdown also reduced
AMPK-α1 protein levels, and this was the case for two different
shRNA constructs (Fig. 6A). Our results conﬁrm previous observations
that knockdown strategies which speciﬁcally target AMPK-α2 efﬁcient-
ly diminish AMPK-α1 concentrations [50]. Together with otherpublications ([51] and references therein), our data demonstrate a
complex regulatory interplay between the two α-subunits that has to
be dissected in the future.
We further assessed the impact of α1- or α2-knockdown on DEM-
induced SGs. In these experiments, mCherry identiﬁed cells transfected
with the silencing construct (Table S1); SGswere then demarcatedwith
G3BP1 (Fig. 6B). G3BP1 presents a robust SG marker for our studies,
because AMPK-α knockdown did not signiﬁcantly alter G3BP1 concen-
trations (Fig. 6 in [39]).
To evaluate SG formation in an unbiased fashion, multiple granule
parameters were quantiﬁed with our established protocols [11]. These
measurements were performed for individual cells or SGs. On the single
cell level, the number of SGs/cell and the total SG area/cell were deter-
mined, while the SG area was calculated for individual granules. Our
methods also inform on the SG composition as it relates to G3BP1.
Speciﬁcally, the pixel intensity for G3BP1/SG area reﬂects the G3BP1
content of the granule.
The comprehensive analyses depicted in Fig. 5C revealed that
targeting AMPK-α2 for knockdown reduced three SG parameters, the
number of SGs/cell, the total SG area/cell and the SG pixel intensity.
The pixel intensity/SG area remained unchanged, indicating that α2-
subunit depletion did not signiﬁcantly alter the G3BP1 content. Unlike
AMPK-α2, the α1-speciﬁc knockdown did not affect any of the SG
characteristics assessed (Fig. 6C). Similar results were obtained for
each of the two α-subunits with two different shRNA constructs (sh1,
sh2). In ethanol-treated control cells no major changes were observed.
Taken together, we established for the ﬁrst time that AMPK deple-
tion impairs the formation of mature SGs. Our measurements of SG
parameters identiﬁed AMPK as a novel regulator that controls several
SG characteristics. Moreover, we uncovered α-isoform-speciﬁc differ-
ences that implicate AMPK-α2 in SG assembly. It is noteworthy that
AMPK-α2 knockdown diminished both α-subunits. It is therefore
possible that AMPK-α2 depletion alone or the concomitant loss of
both α-subunits altered SG characteristics. While our data do not
distinguish between these possibilities, they nevertheless show the
importance of AMPK-α2 for SG biogenesis.
3.6. AMPK depletion diminishes cell survival in stressed cells
SGs regulate the survival of stressed cells; it was therefore possible
that AMPK knockdown alters cell viability under oxidative stress condi-
tions. To address this point, we scored cell death based on the nuclear
morphology, according to established criteria [52]. AMPK-α knockdown
cells were examined in the absence or presence of oxidant. Under stress,
both AMPK-α1 and AMPK-α2 were required for cell survival, as the
percentage of cells with fragmented nuclei increased signiﬁcantly for
all knockdown experiments (Fig. 7). AMPK-α2 knockdown somewhat
increased cell death in ethanol-treated cells, albeit not signiﬁcantly.
Thus, our results indicate that bothα-isoforms contribute to cell surviv-
al in response to stress. As discussed above, AMPK-α2 knockdownmay
elevate cell death due to the loss of AMPK-α2, AMPK-α1 or both. Since
nuclear fragmentation was similar for all AMPK-α knockdown experi-
ments, it is likely that cell death was not primarily due to changes in
SG assembly. It is conceivable that the small SGs produced after
AMPK-α2 knockdown can still prevent extensive cell death.
3.7. AMPK knockdown does not alter the levels of core SG proteins
TIA-1/TIAR, G3BP1 and HuR represent core SG proteins; TIA-1/TIAR
and G3BP1 are especially important, because they nucleate SGs [7]. As
discussed above, CC treatment did not change the levels of these core
SG proteins (Fig. 5C). Similarly, no substantial differenceswere detected
upon knockdown of AMPK-α1 or AMPK-α2 (Fig. 6 in [39]). Our results
support the model that the AMPK-mediated effects on SGs are
downstream of the steps that initiate granule assembly. In this scenario,
AMPK is critical to the generation of mature SGs.
Fig. 11. AMPK activation precedes SG formation. HeLa cells were incubated with DEM for the time points indicated. (A) AMPK-α phosphorylation (p-AMPK-α1/2), total AMPK-α1/2,
phosphorylated Acc1 (p-Acc1, Ser79) and total Acc1 were detected by Western blotting. Controls were incubated with the vehicle ethanol (EtOH). (B) The kinetics for SG formation
was monitored by immunodetection of AMPK-α2 and G3BP1. SGs were formed after 60 min incubation with DEM. They contained the marker G3BP1 and AMPK-α2.
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Our results for CC and AMPK-α2 knockdown are consistent with the
idea that the enzymatic activity of AMPK is critical for the formation of
proper SGs. To further test this hypothesis, we transiently transfectedHeLa cells with myc-tagged AMPK-α2 variants that were dominant
negative (K45R) or constitutively active (T172D). Control cells
produced a biologically inactive myc-tagged form of DNAJA2 [41].
Transfected cells were identiﬁed with antibodies against the myc-tag,
and SG parameters were quantiﬁed for cells treated with DEM or the
Fig. 12. Simpliﬁed model for the role of AMPK in SG biogenesis. Stress induces the transient activation of AMPK and the assembly of SGs (left panel). Reduced AMPK abundance or
activation, achieved through pharmacological inhibition, kinase knockdown or a dominant-negative form of AMPK alters SG parameters, such as number or size.
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not prevent the stress-induced assembly of SGs, but led to a signiﬁcant
reduction of the number of SGs/cell and the total SG area/cell. On the
other hand, constitutive AMPK activation somewhat increased the SG
area, but these changes were not signiﬁcant. Upon transfection some
SGs were also induced in vehicle-treated cells; there was no signiﬁcant
difference between the various plasmids introduced (Fig. 8, EtOH).
Collectively, these results corroborate our CC and knockdown
studies and link AMPK activity to SG biogenesis. Our data also show
that AMPK activation in the absence of stress is not sufﬁcient to induce
SG assembly, a conclusion supported by pharmacological AMPK activa-
tion (data not shown).
3.9. AMPK-α2 physically interacts with G3BP1 in SGs
Experiments described above demonstrate that AMPK-α2 locates to
SGs, but binding partners in the granules are unknown. To begin to
deﬁne the interaction network of AMPK-α2 that is related to SG compo-
nents, we performed in situ proximity ligation assays (PLA) with the
core SG protein G3BP1 as a candidate interactor. G3BP1 and AMPK-α2
were in close proximity in SGs (Fig. 9), and additional interactions
occurred in the cytoplasm, but outside of SGs (Fig. 9A, C). The PLA sig-
nals were speciﬁc, because negative controlsmissing one of the primary
antibodies gave no or only weak signals. To verify that our protocol is
appropriate for the detection of protein–protein interactions in SGs,
we reproduced the association between HuR and TIA (Fig. 9B). FRET
studies showed previously that HuR and TIA interact in SGs [53].
AMPK-α2 binding to the resident SG protein G3BP1 could promote
SG growth through several not mutually exclusive mechanisms. Since
G3BP1 shuttles in and out of SGs [54] it could provide a carrier that
targets AMPK-α2 to the granules. Interestingly, we detected interac-
tions between AMPK-α2 and G3BP1 in the cytoplasm, but outside of
SGs (Fig. 9A, C). These associations could represent an initial contact
that is followed by the movement to SGs. In an alternative scenario,AMPK-α2 may phosphorylate G3BP1 in SGs, and thereby promote SG
maturation through the recruitment of other SG components. Without
AMPK-α2, G3BP1 will still locate to SGs, but the formation of full-size
granules will be prevented.
3.10. Oxidative stress regulates the interaction between AMPK-α2 and
G3BP1
The PLA experiments in Fig. 9 established that AMPK-α2 interacts
with G3BP1 in SGs. We further characterized this interaction by co-
immunoprecipitation experiments in control and DEM-treated cells
(Fig. 10). Immunoprecipitation of G3BP1 co-puriﬁed AMPK-α2, while
nonspeciﬁc binding to isotype control IgG was low. The major AMPK-
α2 band obtained after co-immunoprecipitation was a protein of
~50 kD apparent molecular mass. By contrast, this band was not
puriﬁed with control IgG. As the starting material contained little or
none of the ~50 kD band, it likely represents AMPK-α2 that was cleaved
during the process of immunoprecipitation. To determine whether the
interaction between AMPK-α2 and G3BP1 was controlled by stress we
calculated the ratio AMPK-α2/G3BP1 in immunoprecipitates. These
measurements showed a signiﬁcant increase of AMPK-α2 binding
under stress conditions (Fig. 10). Thus, we provided independent
evidence for the presence of AMPK-α2 and G3BP1 in the same protein
complexes. The formation of these complexes occurs under non-stress
conditions, but is signiﬁcantly increased when cells produce SGs. Our
results provide independent evidence that further substantiates the
model proposed in the previous section. Moreover, it is possible that
SGs serve as a platform that stimulates the interaction between
AMPK-α2 and G3BP1.
3.11. How is AMPK activation linked to SG biogenesis?
CC experiments, AMPK-α2 knockdown and the overexpression of a
dominant-negative AMPK-α2 mutant are consistent with the idea that
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hand, 4 h incubation with DEM reduces the phosphorylation of the α-
subunits on Thr183/Thr172 [37]. To resolve this apparent inconsistency,
we determined the kinetics of AMPK activation and SG formation during
DEM treatment. At early time points (5−20 min) Thr172/Thr183
phosphorylation transiently increases (Fig. 11), and SGs were detected
after 1 h of treatment. Likewise, a transient AMPK activation was also
described for arsenite [55]. Collectively, these data support the interpre-
tation that a transient spike in AMPK activity is a prerequisite for proper
SG maturation.
4. Conclusions
Taken together, we have linked AMPK directly to a hallmark of the
stress response, the assembly of SGs. Our results are summarized in
the simpliﬁedmodel depicted in Fig. 12. In particular, we demonstrated
the isoform-speciﬁc presence of AMPK in SGs, where the kinase inter-
acts with G3BP1. Based on these results, we propose that AMPK is part
of an intracellular signaling hub that is located in SGs.
In line with AMPK's function as a stress sensor, SG formation
preserves energy under detrimental growth conditions [2]. We now
present, for the ﬁrst time, evidence that these two key regulators of
cellular energy homeostasis are directly linked. Given the dynamic
properties of AMPK and the growing number of substrates modiﬁed
by the enzyme, our report sets the stage to explore new directions to
fully understand the physiological roles of AMPK and its isoforms. This
applies in particular to cells exposed to environmental stress or diseases
that are linked to the production of SGs and related granules.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2015.03.015.
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